Literature DB >> 6846020

Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes' classification and to histopathological differentiation. A flow-cytometric DNA study.

B Tribukait, C Hammarberg, C Rubio.   

Abstract

The cellular DNA pattern in 66 colo-rectal adenocarcinomas was studied by means of flow-cytometric DNA analysis. The degree of ploidy and the proportion of cells in S-phase were related to the clinical stage according to Dukes' classification and to the histological differentiation. Multiple cell populations were found in about 60 per cent of the tumours but more frequently in advanced clinical stages. According to the DNA index the cell populations were bimodally distributed with one peak in the diploid-peridiploid region and one peak in the tri- to tetraploid region. In the second group there was a higher frequency of more advanced tumours as compared to the first. The proportion of cells in S-phase was higher in pure diploid tumour cell populations of all clinical stages as compared to normal mucosa but lower as compared to peridiploid and aneuploid cell populations with high DNA index. High as well as low S-phase values may occur in all clinical stages, but a significant higher mean value was found for Dukes' C compared to Dukes' B tumours. Distant metastases occur at all DNA indices and with various S-phase values. In conclusion, tumours of different clinical stages and histological differentiation may be subdivided according to DNA index, to the existence of single or multiple cell populations and to the proportion of cells in S-phase. The biological significance of this subdivision can only be evaluated by means of clinical follow-up.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6846020

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand A        ISSN: 0108-0164


  19 in total

1.  Clinical significance of the DNA index in hematogenous dissemination of aneuploid colorectal cancer.

Authors:  T Yamamoto; K Matsumoto; J Yamamoto; T Kitagawa; C Miki; K Iriyama; H Suzuki
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  Value of flow cytometric determination of ploidy as a guide to prognosis in operable rectal cancer: a multivariate analysis.

Authors:  H S Goh; J R Jass; W S Atkin; J Cuzick; J M Northover
Journal:  Int J Colorectal Dis       Date:  1987-02       Impact factor: 2.571

3.  DNA aneuploidy in ulcerative colitis.

Authors:  J B Fozard; P Quirke; M F Dixon
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

4.  Clinical importance of DNA content in rectal cancer measured by flow cytometry.

Authors:  J R Jass; K Mukawa; H S Goh; S B Love; D Capellaro
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

Review 5.  Clinical and biological significance of aneuploidy in human tumours.

Authors:  M L Friedlander; D W Hedley; I W Taylor
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

6.  Flow cytometric DNA analysis of parathyroid glands. Relationship between nuclear DNA and pathologic classifications.

Authors:  L S Bowlby; L E DeBault; S R Abraham
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

7.  DNA analysis and parathyroid pathology.

Authors:  B K Shenton; H Ellis; I D Johnston; J R Farndon
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

8.  Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development?

Authors:  R Löfberg; B Tribukait; A Ost; O Broström; H Reichard
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

9.  Comparison of nuclear DNA content and exudative stromal reaction between surgical and autopsy materials from gastric and colorectal carcinomas.

Authors:  Y Adachi; M Mori; M Enjoji; K Sugimachi
Journal:  Jpn J Surg       Date:  1988-07

10.  Does in vitro colony formation and chemosensitivity relate to DNA ploidy and S-phase fractions?

Authors:  D Flentje; G Feichter; M Flentje; K L Krämer; K Goerttler; P Schlag
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.